Get the Stockscreener App
24.64
4.05%
0.96
After Hours:
24.28
-0.36
-1.46%
Precipio Inc stock is traded at $24.64, with a volume of 108.32K.
It is up +4.05% in the last 24 hours and up +10.20% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$23.68
Open:
$23.68
24h Volume:
108.32K
Relative Volume:
2.42
Market Cap:
$44.04M
Revenue:
$24.05M
Net Income/Loss:
$-363.00K
P/E Ratio:
-83.55
EPS:
-0.2949
Net Cash Flow:
$359.00K
1W Performance:
+3.53%
1M Performance:
+10.20%
6M Performance:
+4.85%
1Y Performance:
+73.64%
1-Day Range:
$23.10
$24.64
1-Week Range:
$22.60
$25.79
52-Week Range:
$13.02
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
24.64 | 42.32M | 24.05M | -363.00K | 359.00K | -0.2949 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Precipio Inc Stock (PRPO) Latest News
Form 4 Precipio Inc For: 16 July By Investing.com - Investing.com Canada
Precipio (PRPO) director receives 108-share stock grant for Q2-26 service - Stock Titan
Precipio, Inc. (PRPO) director gets 416-share stock grant for Q2 board fees - Stock Titan
Precipio, Inc. (PRPO) director takes stock in lieu of cash pay - Stock Titan
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy? - The Globe and Mail
Liquidity Mapping Around (PRPO) Price Events - Stock Traders Daily
Why (PRPO) Price Action Is Critical for Tactical Trading - Stock Traders Daily
The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio - Yahoo Finance
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Index - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell Microcap Index - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Growth Benchmark - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Precipio Inc. (PRPO) Surges Past Key Resistance Level on Strong MomentumBull Pennant - dars.gov.et
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS of $0.05 Marks a MilestoneEBITDA Margin Trends - dars.gov.et
Price to sales forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to EBITDA forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to revenue forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Precipio Is Requesting Shareholders/Brokers Vote Today to Avoid Costly Adjournment and Rescheduling of Annual Shareholders Meeting - Moomoo
Precipio, Inc. Actuals & Estimates (NASDAQ:PRPO) - TradingView
PRPO Q2 2025 Earnings: Positive Earnings per Share Signal TurnaroundBanking Earnings Report - DonanımHaber
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS of $0.05 Amidst Data Gaps; Stock DeclinesEPS Consistency Score - dars.gov.et
Understanding Momentum Shifts in (PRPO) - Stock Traders Daily
PRPO Q2 2025 Earnings: Positive EPS Achieved Amid Disclosed Revenue ReductionQuarterly Profit Report - DonanımHaber
Precipio Inc (PRPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precipio Inc (PRPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precipio Inc (PRPO) Institutional Confidence - TradingKey
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Precipio Inc (PRPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRPO: Rapid, profitable growth driven by innovative four-hour cancer diagnostics and scalable operations - TradingView
PRPO: Rapid, profitable growth driven by innovative diagnostics and strong customer retention - TradingView
Precipio (PRPO) AGM 2026 Summary - Quartr
Precipio Shareholders Back Board Nominees and Auditor - TipRanks
[8-K] Precipio, Inc. Reports Material Event - Stock Titan
Precipio to Present at the Planet MicroCap Las Vegas - The National Law Review
Precipio Inc Annual Shareholders Meeting Transcript - GuruFocus
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS Achieved Amid Stock DeclineEBITDA Analysis - newsline.com
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - The Manila Times
Precipio urges shareholders to vote ahead of Saturday meeting - Investing.com
Precipio urges shareholders to vote ahead of Saturday meeting By Investing.com - Investing.com Australia
Lack of quorum may force costly delay of Precipio shareholder meeting - Stock Titan
Cancer diagnostics firm Precipio heads to Vegas for Planet MicroCap 2026 - Stock Titan
Precipio to present at Planet MicroCap Las Vega... - Pluang
Avoiding Lag: Real-Time Signals in (PRPO) Movement - Stock Traders Daily
Precipio Inc. (PRPO) Edges Higher Amid Consolidation Near ResistanceShort Setup Alerts - newsline.com
Precipio Inc. (PRPO) Edges Higher as Stock Nears ResistanceSell Signal Alerts - newsline.com
Precipio (PRPO) Q1 2026 Earnings Call Transcript - AOL.com
Precipio Q2 2025 Earnings: Positive EPS Marks a Milestone Despite Market ReactionMargin Compression Risk - newsline.com
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):